Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

The article examines a technology with improved specificity and precision in ultra-sensitive protein immunoassays.

Researchers at Emory University have identified distinct patterns of DNA methylation in Indigenous Andean highlanders that ...

A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...

Researchers have engineered a new class of adenine base editors that reduce unwanted bystander mutations by two to three times compared to the widely used ABE8e, while preserving the editing power ...

Researchers developed FLAV-27, an epigenetic drug that inhibits G9a to restore gene expression in Alzheimer’s models. The treatment reduced amyloid and tau, improved cognition and synaptic function, ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

Maize serves as a vital model species for advancing our understanding of plant biology, yet many mysteries remain about the ...

When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...

For decades, large portions of the human genome were labeled "junk DNA." New research from Western University and London ...